Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6670341 | 7359964 | I | 6670341-6 | 20100318 | 20100322 | 20100405 | EXP | TUK2010A00038 | TAKEDA PHARMACEUTICALS NORTH AMERICA. | YR | M | N | 20100402 | UNITED KINGDOM |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 6670341 | 1013455664 | PS | ACTOS | 1 | 15 MG (15 MG) | U | D | 21073 | |||
| 6670341 | 1013532108 | C | IRBESARTAN | 1 | |||||||
| 6670341 | 1013532109 | C | SITAGLIPTIN | 2 | |||||||
| 6670341 | 1013532110 | C | GLUCOPHAGE | 1 | |||||||
| 6670341 | 1013532112 | C | LIPITOR | 1 | |||||||
| 6670341 | 1013532122 | C | ASPIRIN | 1 |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 6670341 | 1013455664 | TYPE 2 DIABETES MELLITUS |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 6670341 | OT |
Reactions reported
| Event ID | PT |
|---|---|
| 6670341 | ARTHRALGIA |
| 6670341 | DEAFNESS |
| 6670341 | DIZZINESS |
| 6670341 | DYSPNOEA |
| 6670341 | EYE SWELLING |
| 6670341 | HEADACHE |
| 6670341 | HYPOAESTHESIA |
| 6670341 | RENAL PAIN |
| 6670341 | TINNITUS |
| 6670341 | VERTIGO |
| 6670341 | VISION BLURRED |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | RPSR COD |
|---|---|
| 6670341 | FGN |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 6670341 | 1013455664 | 20100317 |